Gilteritinib hemifumarate

Product Specifications

CAS Number

1254053-84-3

Target

FLT|||TAM Receptor

Related Pathways

Tyrosine Kinase/Adaptors|||Angiogenesis

Purity

0.9978

Bioactivity

Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML.

Smiles

C(=C/C(O)=O)\C(O)=O.N(C=1C(C(N)=O)=NC(CC)=C(NC2CCOCC2)N1)C3=CC(OC)=C(C=C3)N4CCC(CC4)N5CCN(C)CC5

Molecular Formula

C29H44N8O3.1/2C4H4O4

Molecular Weight

610.75

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

sc-208323D 250 g

Acetylthiocholine iodide

Ask

View Details

PAV2733 100 μL

Rabbit Anti-ONEC3/ONECUT3 Polyclonal Antibody

Ask

View Details

Z01LS-0722-LS298 5 Plates

Human cTnI (86-90 aa) Matched Antibody Pair Set [Z01LS-0722-LS298]

Ask

View Details

MBS7092304 Inquire

Recombinant Mouse Mitochondrial Rho GTPase 1 (Rhot1), partial

Ask

View Details

TA502964BM 100 µL

SNAP25 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI4C6]

Ask

View Details

QH74953S 200 Tests

Human AMIGO3 qPCR Primer Pair

Ask

View Details